Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53

Abstract

Human esophageal cancer (hESC) cell motility adopts various modes, resulting in hESC progression and poor survival. However, how tripartite motif 59 (TRIM59), as the ubiquitination machinery, participates in hESC metastasis is not completely understood. The results indicated that TRIM59 was aberrantly upregulated in hESC tissues compared with adjacent healthy esophageal tissues, which was associated with poor survival and advanced TNM state among patients with hESC. Moreover, patients with hESC with higher TRIM59 expression displayed undetectable p53 expression, which contributed to enhanced progression and motility of hESC. At the molecular level, TRIM59 was indicated to be an E3 putative ubiquitin ligase that targeted the p53 protein, leading to increased degradation of p53, which resulted in decreased chemosensitivity to cisplatin. TRIM59 knockdown reduced TRIM59 expression, increased p53 protein expression, and decreased hESC cell viability, clone formation and migration compared with the small interfering RNA negative control (siNC) group. Furthermore, hESC cell lines were more sensitive to cisplatin in the TRIM59-knockdown group compared with the siNC group. The results indicated a relationship between TRIM59, p53 and the chemosensitivity of cisplatin. The present study suggested that TRIM59 may serve as a promising prognostic indicator for patients with hESC.

Acidic Tumor Microenvironment Promotes Pancreatic Cancer through miR-451a/MEF2D Axis

“…In brief, PANC-1 cells (3 × 10 3 cells) were inoculated into 96-well plates. After being incubated at 37°C for 24, 48, and 72 h, subsequently, 10 µ L CCK-8 reagent was added to each well and incubated at 37°C for 4 h. This study measured absorbance (OD) at 450 nm using a spectrophotometer (Molecular Device, San Jose, USA) [ 22 ].…”

Tripartite motif family – its role in tumor progression and therapy resistance: a review

“…TRIM27 increased glucose uptake and inhibited the death of esophageal cancer cells [11]. Esophageal cancer tissues show high levels of TRIM59 expression [12]. TRIM15 has also been found overexpressed in esophageal cancer tissues, and it promoted the proliferation, migration and invasion of esophageal cancer cells [13].…”

Beyond Psychotropic: Repurposing of Fluoxetine Toward Cancer Management and Its Molecular Mechanisms

“…In vivo assay showed that FXR, cisplatin, and FXR/cisplatin combination effectively reduced the tumor weight with inhibition rates of 10.9%, 46.6%, and 53.7%, respectively. Mechanistically, FXR/cisplatin upregulated apoptotic proteins caspase-9, p17 and suppressed MDR proteins glutathione S-transferase π (GSTπ) and P-gp [86].…”